Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.

Dardaei L, Wang HQ, Singh M, Fordjour P, Shaw KX, Yoda S, Kerr G, Yu K, Liang J, Cao Y, Chen Y, Lawrence MS, Langenbucher A, Gainor JF, Friboulet L, Dagogo-Jack I, Myers DT, Labrot E, Ruddy D, Parks M, Lee D, DiCecca RH, Moody S, Hao H, Mohseni M, LaMarche M, Williams J, Hoffmaster K, Caponigro G, Shaw AT, Hata AN, Benes CH, Li F, Engelman JA.

Nat Med. 2018 May;24(4):512-517. doi: 10.1038/nm.4497. Epub 2018 Mar 5.

2.

Danshen injection prevents heart failure by attenuating post-infarct remodeling.

Wang L, Yu J, Fordjour PA, Xing X, Gao H, Li Y, Li L, Zhu Y, Gao X, Fan G.

J Ethnopharmacol. 2017 Jun 9;205:22-32. doi: 10.1016/j.jep.2017.04.027. Epub 2017 Apr 30.

PMID:
28465251
3.

MicroRNA-155: a Novel Armamentarium Against Inflammatory Diseases.

Xiaoyan W, Pais EM, Lan L, Jingrui C, Lin M, Fordjour PA, Guanwei F.

Inflammation. 2017 Apr;40(2):708-716. doi: 10.1007/s10753-016-0488-y. Review.

PMID:
27981414
4.

Danshensu Promotes Cholesterol Efflux in RAW264.7 Macrophages.

Gao H, Li L, Li L, Gong B, Dong P, Fordjour PA, Zhu Y, Fan G.

Lipids. 2016 Sep;51(9):1083-92. doi: 10.1007/s11745-016-4178-1. Epub 2016 Aug 11.

PMID:
27514857
5.

Targeting BNIP3 in inflammation-mediated heart failure: a novel concept in heart failure therapy.

Fordjour PA, Wang L, Gao H, Li L, Wang Y, Nyagblordzro M, Agyemang K, Fan G.

Heart Fail Rev. 2016 Sep;21(5):489-97. doi: 10.1007/s10741-016-9557-4. Review.

PMID:
27112557
6.

Anti-Inflammatory Activity of Tanshinone IIA in LPS-Stimulated RAW264.7 Macrophages via miRNAs and TLR4-NF-κB Pathway.

Fan G, Jiang X, Wu X, Fordjour PA, Miao L, Zhang H, Zhu Y, Gao X.

Inflammation. 2016 Feb;39(1):375-384. doi: 10.1007/s10753-015-0259-1.

PMID:
26639663
7.

Possible mechanisms of C-reactive protein mediated acute myocardial infarction.

Fordjour PA, Wang Y, Shi Y, Agyemang K, Akinyi M, Zhang Q, Fan G.

Eur J Pharmacol. 2015 Aug 5;760:72-80. doi: 10.1016/j.ejphar.2015.04.010. Epub 2015 Apr 18. Review.

PMID:
25895642
8.

Respiratory infection.

Fordjour P.

Nurs Stand. 2013 Dec 18;28(16-18):61. doi: 10.7748/ns2013.12.28.16.61.s50. No abstract available.

PMID:
24345155
9.

Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma.

Buonamici S, Williams J, Morrissey M, Wang A, Guo R, Vattay A, Hsiao K, Yuan J, Green J, Ospina B, Yu Q, Ostrom L, Fordjour P, Anderson DL, Monahan JE, Kelleher JF, Peukert S, Pan S, Wu X, Maira SM, García-Echeverría C, Briggs KJ, Watkins DN, Yao YM, Lengauer C, Warmuth M, Sellers WR, Dorsch M.

Sci Transl Med. 2010 Sep 29;2(51):51ra70. doi: 10.1126/scitranslmed.3001599.

10.

The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells.

Jagani Z, Wiederschain D, Loo A, He D, Mosher R, Fordjour P, Monahan J, Morrissey M, Yao YM, Lengauer C, Warmuth M, Sellers WR, Dorsch M.

Cancer Res. 2010 Jul 1;70(13):5528-38. doi: 10.1158/0008-5472.CAN-09-4229. Epub 2010 Jun 8.

11.

Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis.

Wiederschain D, Chen L, Johnson B, Bettano K, Jackson D, Taraszka J, Wang YK, Jones MD, Morrissey M, Deeds J, Mosher R, Fordjour P, Lengauer C, Benson JD.

Mol Cell Biol. 2007 Jul;27(13):4968-79. Epub 2007 Apr 23.

Supplemental Content

Loading ...
Support Center